Wells Fargo & Company Jaguar Health, Inc. Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.08 - $809.55 $20 - $210,483	260 Added 55.67%	727 $0
Q3 2022 Nov 14, 2022	SELL	$0.17 - $765.0 $0 - $1,530	-2 Reduced 0.43%	467 $0
Q2 2022 Aug 12, 2022	BUY	$0.27 - $0.71 $53 - $141	199 Added 73.7%	469 $0
Q1 2022 May 16, 2022	BUY	$0.38 - $1.07 $6 - $18	17 Added 6.72%	270 $0
Q4 2021 Feb 14, 2022	BUY	$1.03 - $2.48 $1 - $2	1 Added 0.4%	253 $0
Q3 2021 Nov 15, 2021	BUY	$2.14 - $4.95 $539 - $1,247	252 New	252 $1,000

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $127M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.